(MHK) Mohawk Industries - Overview
Sector: Consumer Cyclical | Industry: Furnishings, Fixtures & Appliances | Exchange: NYSE (USA) | Market Cap: 6.460m USD | Total Return: 5.2% in 12m
Avg Turnover: 82.8M
EPS Trend: 9.1%
Qual. Beats: 1
Rev. Trend: -73.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Mohawk Industries, Inc. (MHK) is a global manufacturer and distributor of flooring products serving residential and commercial markets. The company operates through three segments: Global Ceramic, Flooring North America, and Flooring Rest of the World. Its diverse product portfolio includes ceramic tile, laminate, wood, carpet, and luxury vinyl tile, marketed under brands such as Daltile, Karastan, and Pergo.
The flooring industry is highly cyclical and maintains a strong correlation with global housing starts and renovation spending. Mohawk utilizes a vertically integrated business model, managing everything from raw material processing to a proprietary distribution network, which helps mitigate supply chain volatility. To further evaluate these operational drivers, investors can find more detailed financial metrics on ValueRay.
Headquartered in Georgia, the company reaches customers through multiple channels, including home centers, independent retailers, and e-commerce platforms. Mohawk also generates revenue by licensing its intellectual property and manufacturing specialized building materials like insulation boards and roofing panels.
- Mortgage rate fluctuations directly impact residential remodeling and new construction demand
- Raw material and energy costs influence manufacturing margins across global segments
- Consumer discretionary spending shifts dictate high-end carpet and luxury vinyl sales
- Global ceramic market share expansion hinges on international housing market recovery
- Commercial construction activity levels drive demand for high-margin carpet tile products
| Net Income: 414.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 1.44 > 1.0 |
| NWC/Revenue: 30.30% < 20% (prev 28.13%; Δ 2.16% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.16b > Net Income 414.4m |
| Net Debt (1.77b) to EBITDA (1.19b): 1.49 < 3 |
| Current Ratio: 2.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.7m) vs 12m ago -1.91% < -2% |
| Gross Margin: 24.34% > 18% (prev 0.25%; Δ 2.41k% > 0.5%) |
| Asset Turnover: 80.80% > 50% (prev 79.68%; Δ 1.12% > 0%) |
| Interest Coverage Ratio: 36.90 > 6 (EBITDA TTM 1.19b / Interest Expense TTM 13.6m) |
| A: 0.24 (Total Current Assets 6.20b - Total Current Liabilities 2.87b) / Total Assets 13.8b |
| B: 0.55 (Retained Earnings 7.56b / Total Assets 13.8b) |
| C: 0.04 (EBIT TTM 501.8m / Avg Total Assets 13.6b) |
| D: 1.40 (Book Value of Equity 7.56b / Total Liabilities 5.41b) |
| Altman-Z'' = 5.08 = AAA |
| DSRI: 0.96 (Receivables 2.09b/2.13b, Revenue 11.0b/10.7b) |
| GMI: 1.01 (GM 24.34% / 24.54%) |
| AQI: 1.03 (AQ_t 0.18 / AQ_t-1 0.18) |
| SGI: 1.03 (Revenue 11.0b / 10.7b) |
| TATA: -0.05 (NI 414.4m - CFO 1.16b) / TA 13.8b) |
| Beneish M = -3.07 (Cap -4..+1) = AA |
As of May 31, 2026, the stock is trading at USD 107.42 with a total of 325,166 shares traded.
Over the past week, the price has changed by +4.97%,
over one month by +4.40%,
over three months by -14.25% and
over the past year by +5.18%.
Mohawk Industries has received a consensus analysts rating of 3.83. Therefore, it is recommended to buy MHK.
- StrongBuy: 6
- Buy: 3
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 120.5 | 12.1% |
P/E Trailing = 15.8653
P/E Forward = 12.5
P/S = 0.5879
P/B = 0.7713
P/EG = 0.6406
Revenue TTM = 11.0b USD
EBIT TTM = 501.8m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 501.1m USD (from shortTermDebt, last quarter)
Debt = 2.64b USD (corrected: LT Debt 1.73b + ST Debt 501.1m) + Leases 412.2m
Net Debt = 1.77b USD (calculated: Debt 2.64b - CCE 872.3m)
Enterprise Value = 8.23b USD (6.46b + Debt 2.64b - CCE 872.3m)
Interest Coverage Ratio = 36.90 (Ebit TTM 501.8m / Interest Expense TTM 13.6m)
EV/FCF = 11.60x (Enterprise Value 8.23b / FCF TTM 709.4m)
FCF Yield = 8.62% (FCF TTM 709.4m / Enterprise Value 8.23b)
FCF Margin = 6.46% (FCF TTM 709.4m / Revenue TTM 11.0b)
Net Margin = 3.77% (Net Income TTM 414.4m / Revenue TTM 11.0b)
Gross Margin = 24.34% ((Revenue TTM 11.0b - Cost of Revenue TTM 8.31b) / Revenue TTM)
Gross Margin QoQ = 23.52% (prev 24.57%)
Tobins Q-Ratio = 0.60 (Enterprise Value 8.23b / Total Assets 13.8b)
Interest Expense / Debt = 0.51% (Interest Expense 13.6m / Debt 2.64b)
Taxrate = 21.08% (98.8m / 468.7m)
NOPAT = 396.0m (EBIT 501.8m * (1 - 21.08%))
Current Ratio = 2.16 (Total Current Assets 6.20b / Total Current Liabilities 2.87b)
Debt / Equity = 0.32 (Debt 2.64b / totalStockholderEquity, last quarter 8.38b)
Debt / EBITDA = 1.49 (Net Debt 1.77b / EBITDA 1.19b)
Debt / FCF = 2.50 (Net Debt 1.77b / FCF TTM 709.4m)
Total Stockholder Equity = 8.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.05% (Net Income 414.4m / Total Assets 13.8b)
RoE = 4.96% (Net Income TTM 414.4m / Total Stockholder Equity 8.35b)
RoCE = 4.98% (EBIT 501.8m / Capital Employed (Equity 8.35b + L.T.Debt 1.73b))
RoIC = 3.49% (NOPAT 396.0m / Invested Capital 11.4b)
WACC = 7.39% (E(6.46b)/V(9.10b) * Re(10.25%) + D(2.64b)/V(9.10b) * Rd(0.51%) * (1-Tc(0.21)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -95.56 | Cagr: -1.57%
[DCF] Terminal Value 77.97% ; FCFF base≈624.5m ; Y1≈715.9m ; Y5≈1.05b
[DCF] Fair Price = 231.1 (EV 15.9b - Net Debt 1.77b = Equity 14.1b / Shares 61.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 9.09 | EPS CAGR: 0.37% | SUE: 1.05 | # QB: 1
Revenue Correlation: -73.72 | Revenue CAGR: -1.54% | SUE: -0.16 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.58 | Chg30d=-9.38% | Revisions=-62% | Analysts=17
EPS next Quarter (2026-09-30): EPS=2.39 | Chg30d=-15.20% | Revisions=-81% | Analysts=17
EPS current Year (2026-12-31): EPS=8.58 | Chg30d=-10.16% | Revisions=-81% | GrowthEPS=-4.2% | GrowthRev=+1.6%
EPS next Year (2027-12-31): EPS=9.90 | Chg30d=-10.25% | Revisions=-70% | GrowthEPS=+15.4% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: -81%